Primary Care

In this podcast, Joëlle E. Vergroesen, MSc, discusses the results of her team's study examining how the use of metformin, insulin, and sulfonylurea derivatives may impact the risk of open-angle glaucoma,...

In their single-center study, Viral Shah, MD, and his research team analyzed the association between diabetes technology use and mean clinic hemoglobin A1C among adults with type 1 diabetes.

In this video, James Matera, DO, speaks with nephrologist Wayne Kotzker, MD, primary care physician, Maria Ciminelli, MD, cardiologist Lance Berger, MD, and nutritionist Jamie Miller, RD, about the role of...

Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.

In this episode, Dr Harrison discusses a case presentation of a 65-year-old man with chronic obstructive pulmonary disease, hypertension, and type 2 diabetes, who presents with headaches and bilateral...

In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...

In this podcast, Caroline Trapp, DNP, ANP-BC, CDCES, talks about ways to achieve partial and full remission of type 2 diabetes and how certified diabetes care and education specialists can identify the type...

In this video, Amy S. Paller, MD, discusses the efficacy and safety of dupilumab for patients with erythrodermic atopic dermatitis (AD), what these results mean for patients with severe AD, and how her...

In this video, Brett Snodgrass, a nurse practitioner, provides the take-home messages from her session "Digging Deeper: Substance Use Disorder” at our Practical Updates in Primary Care 2023 Virtual Series....

In this video, Karlijn Burridge, PA-C, obesity medicine specialist at Enara Health in Glen Ellyn, Illinois, provides the take-home messages from her session at our Practical Updates in Primary Care 2023...